[3D] Mechanism of Iressa Drug Resistance

Loading...

Sign in or sign up now!
152 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jan 13, 2012

Note on 3D video: 3D videos on youtube are best viewed with a 3D viewing system such as a 3D TV or a stereoscopic 3D capable computer. There is an option for colored glasses, but youtube does the conversion so unless your glasses match youtube's specifications, they won't work as well. If you don't have a viewing system you can try the no glasses option: you can view the video in 3D by crossing your eyes to merge the left and right view, similar to how stereograms work. However this can be difficult to pull off and could give you a headache.

Protein kinases are a group of enzymes that transfer a phosphate from a molecule, such as the cofactor ATP, to one or more amino acid residues in a signaling protein. Over-functioning results in uncontrollable growth of cells, a tumor formation. ATP binds in the ATP-binding site of the tyrosine kinase domain and makes 2 important hydrogen bonds to the protein. A threonine side-chain at position 790 is present in the binding interaction. The binding of ATP to the tyrosine kinase domain of the protein leads to phosphorylation of the tyrosine residue, and as a result, proliferation of cells. The drug Iressa or Gefitinib is a Tyrosine Kinase inhibitor that blocks the binding of ATP, and thus no phosphorylation. Although it is similar in size, Iressa does not resemble the structure of the ATP molecule, but the drug binds in the ATP-binding pocket and prevents the protein from phosphorylation.

  • likes, 0 dislikes

Link to this comment:

Share to:

Video Responses

This video is a response to Mechanism of Iressa Drug Resistance
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Hot.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more